Skip to content

Development and validation of Chemotherapy-Related Cognitive Impairment Intervention for patients with Breast Cancer

Development and validation of Chemotherapy-Related Cognitive Impairment Intervention for patients with Breast Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121826
Enrollment
Unknown
Registered
2026-04-03
Start date
2026-04-13
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Intervention group:CRCI intervention scheme constructed in this study.
Control group:Routine nursing

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of breast cancer; 2. Initial treatment, chemotherapy planned; 3. Age >= 18 years; 4. Informed consent, patient voluntarily participates in this study.

Exclusion criteria

Exclusion criteria: 1. Presence of concurrent malignancies; 2. Patients with brain metastases, or severe systemic diseases affecting major organs (e.g., heart, brain, lungs, kidneys); 3. History of psychiatric disorders, or impaired verbal/written communication abilities.

Design outcomes

Primary

MeasureTime frame
Functional Assessment of Cancer Therapy-Cognitive Function Score ;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index, PSQI;Hospital Anxiety and Depression Scale Score;Functional Assessment of Chronic Illness Therapy-Fatigue Score;Quality of Life Assessment Form for Breast Cancer Patients Score;

Countries

China

Contacts

Public ContactMou Qianqian

West China Hospital, Sichuan University

muqian1024@126.com+86 153 0808 1210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026